Viewing Company
Company Name:
Ascendis Pharma A/S
CIK:
1612042
Phone:
None
Fiscal Year End:
None
Entity Type:
SIC:
-
Category Type:
Entity Name:
None
First Filing Date:
2018-03-28
Last Filing Date:
2025-05-01
SEC Filings
| Start | End | Frame | Filed | ACCN | Value | View |
|---|---|---|---|---|---|---|
| 2021-01-01 | 2021-03-31 | CY2020Q1 | 2021-05-27 | 0001193125-21-175492 | $ 53,759,952 | View |
| 2021-04-01 | 2021-06-30 | CY2020Q2 | 2021-08-27 | 0001193125-21-257913 | $ 53,848,166 | View |
| 2020-01-01 | 2020-12-31 | CY2018 | 2021-03-10 | 0001193125-21-076349 | $ 50,616,528 | View |
| 2021-01-01 | 2021-12-31 | CY2019Q4I | 2022-03-02 | 0001193125-22-062998 | $ 68,865,000 | View |
| 2018-04-01 | 2018-06-30 | CY2017Q2 | 2018-08-29 | 0001193125-18-262034 | $ 41,650,907 | View |
| 2020-01-01 | 2020-03-31 | CY2019Q1 | 2020-05-19 | 0001193125-20-146167 | $ 47,985,837 | View |
| 2020-04-01 | 2020-06-30 | CY2019Q2 | 2020-08-27 | 0001193125-20-233148 | $ 48,207,661 | View |
| 2019-01-01 | 2019-12-31 | CY2017 | 2020-04-03 | 0001193125-20-096870 | $ 46,506,862 | View |
| 2017-01-01 | 2017-12-31 | CY2015 | 2018-03-28 | 0001193125-18-099514 | $ 33,626,305 | View |
| 2018-01-01 | 2018-03-31 | CY2017Q1 | 2018-05-30 | 0001193125-18-178428 | $ 38,699,204 | View |
| 2018-01-01 | 2018-12-31 | CY2016 | 2019-04-03 | 0001193125-19-096759 | $ 41,085,237 | View |
| 2018-07-01 | 2018-09-30 | CY2017Q3 | 2018-11-28 | 0001193125-18-336571 | $ 41,888,908 | View |
| 2019-01-01 | 2019-03-31 | CY2018Q1 | 2019-05-30 | 0001193125-19-161327 | $ 43,371,559 | View |
| 2019-04-01 | 2019-06-30 | CY2018Q2 | 2019-08-28 | 0001193125-19-232458 | $ 47,190,717 | View |
| 2019-07-01 | 2019-09-30 | CY2018Q3 | 2019-11-18 | 0001193125-19-294735 | $ 47,590,837 | View |
| 2023-01-01 | 2023-03-31 | CY2022Q1 | 2023-04-27 | 0000950170-23-015250 | $ -256,000 | View |
| 2020-07-01 | 2020-09-30 | CY2019Q3 | 2020-11-12 | 0001193125-20-290930 | $ 52,715,204 | View |
| 2021-07-01 | 2021-09-30 | CY2020Q3 | 2021-11-10 | 0001193125-21-326004 | $ 54,639,597 | View |
| 2022-01-01 | 2022-03-31 | CY2022Q1I | 2022-05-11 | 0001193125-22-147494 | $ 8,926,000 | View |
| 2022-04-01 | 2022-06-30 | CY2022Q2I | 2022-08-10 | 0001193125-22-217358 | $ 14,079,000 | View |
| 2022-07-01 | 2022-09-30 | CY2022Q3I | 2022-11-02 | 0000950170-22-021277 | $ 16,100,000 | View |
| 2024-01-01 | 2024-03-31 | CY2023Q1 | 2024-05-02 | 0000950170-24-052182 | $ 2,786,000 | View |
| 2024-01-01 | 2024-06-30 | CY2024Q2I | 2024-09-03 | 0000950170-24-102919 | $ 7,354,000 | View |
| 2024-01-01 | 2024-09-30 | CY2024Q3I | 2024-11-14 | 0000950170-24-127079 | $ 7,354,000 | View |
| 2024-01-01 | 2024-12-31 | CY2024 | 2025-02-12 | 0000950170-25-018852 | $ 0 | View |
| 2025-01-01 | 2025-03-31 | CY2025Q1 | 2025-05-01 | 0000950170-25-061850 | $ 7,500,000 | View |
| 2022-01-01 | 2021-12-31 | CY2021Q4I | 2023-02-16 | 0000950170-23-003068 | $ 199,900,000 | View |
| 2023-01-01 | 2023-06-30 | CY2023Q2I | 2023-09-05 | 0000950170-23-046393 | $ -9,118,000 | View |
| 2023-01-01 | 2023-09-30 | CY2023Q3I | 2023-11-07 | 0000950170-23-060212 | $ 139,782,000 | View |
| 2023-01-01 | 2023-12-31 | CY2021 | 2024-02-07 | 0000950170-24-012212 | $ 5,830,000 | View |
SEC Facts By Type
| Type | Name | Description | View |
|---|---|---|---|
| dei | Entity Common Stock, Shares Outstanding | Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. | View |
| ifrs-full | 3934858 | None | View |